Prolintane

Prolintane (Catovit, Katovit, Promotil, Villescon) is a stimulant[1] and norepinephrine-dopamine reuptake inhibitor developed in the 1950s.[2] It is closely related in chemical structure to other drugs such as pyrovalerone, MDPV, and propylhexedrine and it has a similar mechanism of action.[3] Many cases of prolintane abuse have been reported.[4]

Prolintane
Clinical data
Routes of
administration		oral, intranasal, rectal
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
ECHA InfoCard100.007.077
Chemical and physical data
FormulaC15H23N
Molar mass217.35 g/mol g·mol−1
3D model (JSmol)
Melting point133 °C (271 °F)
Boiling point153 °C (307 °F)
 NY (what is this?)  (verify)

Under the trade-name "Katovit", prolintane was commercialized by the Spanish pharmaceutical company, FHER. Katovit was sold until 2001, and was most often used by students and workers as a stimulant to provide energy, promote alertness and concentration.

See also

References
  1. Hollister, L. E.; Gillespie, H. K. (March–April 1970). "A New Stimulant, Prolintane Hydrochloride, Compared with Dextroamphetamine in Fatigued Volunteers". The Journal of Clinical Pharmacology. 10 (2): 103–109. doi:10.1177/009127007001000205. PMID 4392006.
  2. GB Patent 807835
  3. Nicholson, A. N.; Stone, B. M.; Jones, M. M. (November 1980). "Wakefullness and reduced rapid eye movement sleep: studies with prolintane and pemoline". British Journal of Clinical Pharmacology. 10 (5): 465–472. doi:10.1111/j.1365-2125.1980.tb01790.x. PMC 1430138. PMID 7437258.
  4. Kyle, P. B.; Daley, W. P. (September 2007). "Domestic Abuse of the European Rave Drug Prolintane". Journal of Analytical Toxicology. 31 (7): 415–418. doi:10.1093/jat/31.7.415. PMID 17725890.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.